Discovery - University of Dundee - Online Publications

Library & Learning Centre

Oncogene

  1. Crosstalk between NRF2 and HIPK2 shapes cytoprotective responses

    Torrente, L., Sanchez, C., Moreno Dorta, R., Chowdhry, S., Cabello, P., Isono, K., Koseki, H., Honda, T., Hayes, J., Dinkova-Kostova, A. & de la Vega, L. 2 Nov 2017 In : Oncogene. 36, 44, p. 6204-6212 9 p.

    Research output: Contribution to journalArticle

  2. AKT overactivation can suppress DNA repair via p70S6 kinase-dependent downregulation of MRE11

    Piscitello, D., Varshney, D., Lilla, S., Vizioli, M. G., Reid, C., Gorbunova, V., Seluanov, A., Gillespie, D. A. & Adams, P. D. 2 Oct 2017 In : Oncogene. 12 p.

    Research output: Contribution to journalArticle

  3. P38 delta MAPK promotes breast cancer progression and lung metastasis by enhancing cell proliferation and cell detachment

    Wada, M., Canals, D., Adada, M., Coant, N., Salama, M. F., Helke, K. L., Arthur, J. S., Shroyer, K. R., Kitatani, K., Obeid, L. M. & Hannun, Y. A. 7 Aug 2017 In : Oncogene. 36, p. 6649-6657 9 p.

    Research output: Contribution to journalArticle

  4. Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome

    Walls, G. V., Stevenson, M., Lines, K. E., Newey, P. J., Reed, A. A. C., Bowl, M. R., Jeyabalan, J., Harding, B., Bradley, K. J., Manek, S., Chen, J., Wang, P. Z., Williams, B. O., Teh, B. T. & Thakker, R. V. 13 Jul 2017 In : Oncogene. 36, 28, p. 4025-4036 12 p.

    Research output: Contribution to journalArticle

  5. WNT/β-catenin signaling regulates mitochondrial activity to alter the oncogenic potential of melanoma in a PTEN-dependent manner

    Brown, K., Yang, P., Nobre Salvador, D., Kulikauskas, R., Ruohola-Baker, H., Robitaille, A. M., Chien, A. J., Moon, R. T. & Sherwood, V. 1 Jun 2017 In : Oncogene. 36, 22, p. 3119-3136 18 p.

    Research output: Contribution to journalArticle

  6. Inhibition of cholesterol metabolism underlies synergy between mTOR pathway inhibition and chloroquine in bladder cancer cells

    King, M. A., Ganley, I. G. & Flemington, V. 25 Aug 2016 In : Oncogene. 35, 34, p. 4518-4528 11 p.

    Research output: Contribution to journalArticle

  7. The heparan sulfate sulfotransferase 3-OST3A (HS3ST3A) is a novel tumor regulator and a prognostic marker in breast cancer

    Mao, X., Gauche, C., Coughtrie, M. W. H., Bui, C., Gulberti, S., Merhi-Soussi, F., Ramalanjaona, N., Bertin-Jung, I., Diot, A., Dumas, D., De Freitas Caires, N., Thompson, A. M., Bourdon, J-C., Ouzzine, M. & Fournel-Gigleux, S. 4 Apr 2016 In : Oncogene. 35, p. 5043-5055 13 p.

    Research output: Contribution to journalArticle

  8. The NEDD8 inhibitor MLN4924 increases the size of the nucleolus and activates p53 through the ribosomal-Mdm2 pathway

    Bailly, A., Perrin, A., Bou Malhab, L. J., Pion, E., Larance, M., Nagala, M., Smith, P., O'Donohue, M-F., Gleizes, P-E., Zomerdijk, J., Lamond, A. I. & Xirodimas, D. P. 28 Jan 2016 In : Oncogene. 35, 4, p. 415-426 12 p.

    Research output: Contribution to journalArticle

  9. PML isoforms IV and V contribute to adenovirus-mediated oncogenic transformation by functionally inhibiting the tumor-suppressor p53

    Wimmer, P., Berscheminski, J., Blanchette, P., Groitl, P., Branton, P. E., Hay, R. T., Dobner, T. & Schreiner, S. 7 Jan 2016 In : Oncogene. 35, p. 69-82 14 p.

    Research output: Contribution to journalArticle

  10. Prohibitin is required for transcriptional repression by the WT1-BASP1 complex

    Toska, E., Shandilya, J., Goodfellow, S. J., Medler, K. F. & Roberts, S. G. E. 23 Oct 2014 In : Oncogene. 33, 43, p. 5100-5108 9 p.

    Research output: Contribution to journalArticle

  11. The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a.

    Sparks, A., Dayal, S., Das, J., Robertson, P., Menendez, S. & Saville, M. K. Oct 2014 In : Oncogene. 33, 38, p. 4685-4696 12 p.

    Research output: Contribution to journalArticle

  12. PDK1 controls upstream PI3K expression and PIP3 generation

    Dieterle, A. M., Böhler, P., Keppeler, H., Alers, S., Berleth, N., Drießen, S., Hieke, N., Pietkiewicz, S., Löffler, A. S., Peter, C., Gray, A., Leslie, N. R., Shinohara, H., Kurosaki, T., Engelke, M., Wienands, J., Bonin, M., Wesselborg, S. & Stork, B. 5 Jun 2014 In : Oncogene. 33, 23, p. 3043-3053 11 p.

    Research output: Contribution to journalArticle

  13. HIF-independent role of prolyl hydroxylases in the cellular response to amino acids

    Durán, R. V., Mackenzie, E. D., Boulahbel, H., Frezza, C., Heiserich, L., Tardito, S., Bussolati, O., Rocha, S., Hall, M. N. & Gottlieb, E. 19 Sep 2013 In : Oncogene. 32, 38, p. 4549-4556 8 p.

    Research output: Contribution to journalArticle

  14. The RNA helicase p68 (DDX5) is selectively required for the induction of p53-dependent p21 expression and cell-cycle arrest after DNA damage

    Nicol, S. M., Bray, S. E., Derek Black, H., Lorimore, S. A., Wright, E. G., Lane, D. P., Meek, D. W., Coates, P. J. & Fuller-Pace, F. V. 18 Jul 2013 In : Oncogene. 32, 29, p. 3461-3469 9 p.

    Research output: Contribution to journalArticle

  15. The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression

    Bernard, H., Garmy-Susini, B., Ainaoui, N., Van Den Berghe, L., Peurichard, A., Javerzat, S., Bikfalvi, A., Lane, D. P., Bourdon, J. C. & Prats, A-C. 25 Apr 2013 In : Oncogene. 32, 17, p. 2150-2160 11 p.

    Research output: Contribution to journalArticle

  16. p53 is activated in response to disruption of the pre-mRNA splicing machinery

    Allende-Vega, N., Dayal, S., Agarwala, U., Sparks, A., Bourdon, J-C. & Saville, M. K. 3 Jan 2013 In : Oncogene. 32, 1, p. 1-14 14 p.

    Research output: Contribution to journalArticle

  17. Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia

    Ånensen, N., Hjelle, S. M., Van Belle, W., Haaland, I., Silden, E., Bourdon, J-C., Hovland, R., Taskén, K., Knappskog, S., Lønning, P. E., Bruserud, O. & Gjertsen, B. T. 2012 In : Oncogene. 31, 12, p. 1533-1545 13 p.

    Research output: Contribution to journalArticle

  18. C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balances

    Muller, P., Ruckova, E., Halada, P., Coates, P. J., Hrstka, R., Lane, D. P. & Vojtesek, B. 2012 In : Oncogene.

    Research output: Contribution to journalArticle

  19. Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity

    Chowdhry, S., Zhang, Y., McMahon, M., Sutherland, C., Cuadrado, A. & Hayes, J. D. 2012 In : Oncogene. 32, p. 3765-3781 17 p.

    Research output: Contribution to journalArticle

  20. Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinoma

    Watt, S., Pourreyron, C., Purdie, K., Hogan, C., Cole, C. L., Foster, N., Pratt, N., Bourdon, J-C., Appleyard, V., Murray, K., Thompson, A., Mao, X., Mein, C., Bruckner-Tuderman, L., Evans, A., McGrath, J. A., Proby, C. M., Foerster, J., Leigh, I. & South, A. Nov 2011 In : Oncogene. 30, 46, p. 4666-4677 12 p.

    Research output: Contribution to journalArticle

  21. Absence of the Birt-Hogg-Dube gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibility

    Preston, R. S., Philp, A., Claessens, T., Gijezen, L., Dydensborg, A. B., Dunlop, E. A., Harper, K. T., Brinkhuizen, T., Menko, F. H., Davies, D. M., Land, S. C., Pause, A., Baar, K., van Steensel, M. & Tee, A. R. 2011 In : Oncogene. 30, 10, p. 1159-1173 15 p.

    Research output: Contribution to journalArticle

  22. Cdc25B is negatively regulated by p53 through Sp1 and NF-Y transcription factors

    Dalvai, M., Mondesert, O., Bourdon, J-C., Ducommun, B. & Dozier, C. 2011 In : Oncogene. 30, 19, p. 2282-2288 7 p.

    Research output: Contribution to journalArticle

  23. Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome

    Henry, L. A., Johnson, D. A., Sarrio, D., Lee, S., Quinlan, P. R., Crook, T., Thompson, A. M., Reis-Filho, J. S. & Isacke, C. M. 2011 In : Oncogene. 30, 9, p. 1046-1058 13 p.

    Research output: Contribution to journalArticle

  24. Defining the role of APC in the mitotic spindle checkpoint in vivo: APC-deficient cells are resistant to Taxol

    Radulescu, S., Ridgway, R. A., Appleton, P., Kroboth, K., Patel, S., Woodgett, J., Taylor, S., Nathke, I. S. & Sansom, O. J. Dec 2010 In : Oncogene. 29, 49, p. 6418-6427 10 p.

    Research output: Contribution to journalArticle

  25. The RNA helicase p68 modulates expression and function of the Delta 133 isoform(s) of p53, and is inversely associated with Delta 133p53 expression in breast cancer

    Moore, H. C., Jordan, L. B., Bray, S. E., Baker, L., Quinlan, P. R., Purdie, C. A., Thompson, A. M., Bourdon, J-C. & Fuller-Pace, F. V. Dec 2010 In : Oncogene. 29, 49, p. 6475-6484 10 p.

    Research output: Contribution to journalArticle

  26. Enhanced mRNA cap methylation increases Cyclin D1 expression and promotes cell transformation

    Cowling, V. H. 11 Feb 2010 In : Oncogene. 29, 6, p. 930-936 7 p.

    Research output: Contribution to journalArticle

  27. Suppression of cellular proliferation and invasion by the concerted lipid and protein phosphatase activities of PTEN

    Davidson, L., Maccario, H., Perera, N. M., Yang, X., Spinelli, L., Tibarewal, P., Glancy, B., Gray, A., Weijer, C. J., Downes, C. P. & Leslie, N. R. 4 Feb 2010 In : Oncogene. 29, 5, p. 687-697 11 p.

    Research output: Contribution to journalArticle

  28. MdmX is a substrate for the deubiquitinating enzyme USP2a

    Allende-Vega, N., Sparks, A., Lane, D. P. & Saville, M. K. 21 Jan 2010 In : Oncogene. 29, 3, p. 432-441 10 p.

    Research output: Contribution to journalArticle

  29. The DEAD-box protein p72 regulates ER alpha-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ER alpha-positive breast cancer

    Wortham, N. C., Ahamed, E., Nicol, S. M., Thomas, R. S., Periyasamy, M., Jiang, J., Ochocka, A. M., Shousha, S., Huson, L., Bray, S. E., Coombes, R. C., Ali, S. & Fuller-Pace, F. V. 19 Nov 2009 In : Oncogene. 28, 46, p. 4053-4064 12 p.

    Research output: Contribution to journalArticle

  30. Specific regulation of mRNA cap methylation by the c-Myc and E2F1 transcription factors

    Cole, M. D. & Cowling, V. H. 5 Mar 2009 In : Oncogene. 28, 9, p. 1169-1175 7 p.

    Research output: Contribution to journalArticle

  31. TGF-beta-mediated activation of RhoA signalling is required for efficient (V12)HaRas and (V600E)BRAF transformation

    Fleming, Y. M., Ferguson, G. J., Spender, L. C., Larsson, J., Karlsson, S., Ozanne, B. W., Grosse, R. & Inman, G. J. 19 Feb 2009 In : Oncogene. 28, 7, p. 983-993 11 p.

    Research output: Contribution to journalArticle

  32. Understanding PTEN regulation: PIP, polarity and protein stability

    Leslie, N. R., Batty, I. H., Maccario, H., Davidson, L. & Downes, C. P. 15 Sep 2008 In : Oncogene. 27, 41, p. 5464-5476 13 p.

    Research output: Contribution to journalArticle

  33. The regulatory beta-subunit of protein kinase CK2 regulates cell-cycle progression at the onset of mitosis

    Yde, C. W., Olsen, B. B., Meek, D., Watanabe, N. & Guerra, B. 28 Aug 2008 In : Oncogene. 27, 37, p. 4986-4997 12 p.

    Research output: Contribution to journalArticle

  34. Aberrant expression of extracellular signal-regulated kinase 5 in human prostate cancer

    McCracken, S. R. C., Ramsay, A., Heer, R., Mathers, M. E., Jenkins, B. L., Edwards, J., Robson, C. N., Marquez, R., Cohen, P. & Leung, H. Y. 8 May 2008 In : Oncogene. 27, 21, p. 2978-2988 11 p.

    Research output: Contribution to journalArticle

  35. An N-Myc truncation analogous to c-Myc-S induces cell proliferation independently of transactivation but dependent on Myc homology box II

    Cowling, V. H. & Cole, M. D. 21 Feb 2008 In : Oncogene. 27, 9, p. 1327-1332 6 p.

    Research output: Contribution to journalArticle

  36. Drosophila asymmetric division, polarity and cancer

    Januschke, J. & Gonzalez, C. 2008 In : Oncogene. 27, 55, p. 6994-7002 9 p.

    Research output: Contribution to journalArticle

  37. Loss of PTEN selectively desensitizes upstream IGF1 and insulin signaling

    Lackey, J., Barnett, J., Davidson, L., Batty, I. H., Leslie, N. R. & Downes, C. P. Nov 2007 In : Oncogene. 26, 50, p. 7132-7142 11 p.

    Research output: Contribution to journalArticle

  38. SUMO modification of the DEAD box protein p68 modulates its transcriptional activity and promotes its interaction with HDAC1

    Jacobs, A-M., Nicol, S. M., Hislop, R. G., Jaffray, E. G., Hay, R. T. & Fuller-Pace, F. V. 30 Aug 2007 In : Oncogene. 26, 40, p. 5866-76 11 p.

    Research output: Contribution to journalArticle

  39. Regulation of ATR-dependent pathways by the FHA domain containing protein SNIP1

    Roche, K. C., Rocha, S., Bracken, C. P. & Perkins, N. D. 5 Jul 2007 In : Oncogene. 26, 31, p. 4523-30 8 p.

    Research output: Contribution to journalArticle

  40. Highlights of the 23rd Genes and Cancer meeting University of Warwick 11-13 December 2006

    Labib, K. 26 Apr 2007 In : Oncogene. 26, 19, p. 2675-2677 3 p.

    Research output: Contribution to journalEditorial

  41. HIF-1α contributes to tumour-selective killing by the sigma receptor antagonist rimcazole

    Achison, M., Boylan, M. T., Hupp, T. R. & Spruce, B. A. 22 Feb 2007 In : Oncogene. 26, 8, p. 1137-1146 10 p.

    Research output: Contribution to journalArticle

  42. Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases

    Owens, D. M. & Keyse, S. M. 2007 In : Oncogene. 26, 22, p. 3203-13 11 p.

    Research output: Contribution to journalArticle

  43. E-cadherin repression contributes to c-Myc-induced epithelial cell transformation

    Cowling, V. H. & Cole, M. D. 2007 In : Oncogene. 26, 24, p. 3582-6 5 p.

    Research output: Contribution to journalArticle

  44. Evaluation of the 3p21.3 tumour-suppressor gene cluster

    Hesson, L. B., Cooper, W. N. & Latif, F. 2007 In : Oncogene. 26, 52, p. 7283-7301 19 p.

    Research output: Contribution to journalArticle

  45. Transcription factor TAFII250 promotes Mdm2-dependent turnover of p53

    Allende-Vega, N., Saville, M. K. & Meek, D. W. 2007 In : Oncogene. 26, 29, p. 4234-4242 9 p.

    Research output: Contribution to journalArticle

  46. Ubiquitin-independent degradation of p53 mediated by high-risk human papillomavirus protein E6

    Camus, S., Menendez, S., Cheok, C. F., Stevenson, L. F., Lain, S. & Lane, D. P. 2007 In : Oncogene. 26, 28, p. 4059-4070 12 p.

    Research output: Contribution to journalArticle

  47. A functional analysis of PCNA-binding peptides derived from protein sequence, interaction screening and rational design

    Warbrick, E. 2006 In : Oncogene. 25, 20, p. 2850-2859 10 p.

    Research output: Contribution to journalArticle

  48. c-Abl phosphorylates Hdm2 at tyrosine 276 in response to DNA damage and regulates interaction with ARF

    Dias, S. S., Milne, D. M. & Meek, D. W. 2006 In : Oncogene. 25, 50, p. 6666-6671 6 p.

    Research output: Contribution to journalArticle

  49. The 'regulatory' β-subunit of protein kinase CK2 negatively influences p53-mediated allosteric effects on Chk2 activation

    Bjørling-Poulsen, M., Siehler, S., Wiesmüller, L., Meek, D., Niefind, K. & Issinger, O-G. 8 Sep 2005 In : Oncogene. 24, 40, p. 6194-6200 7 p.

    Research output: Contribution to journalArticle

Previous 1 2 Next

Library & Learning Centre

Contact | Accessibility | Policy